Evidence map›Paper›PMID 22696686›Full record

ArticleAnnals of the rheumatic diseases2012

Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein.

Angélica M Delgado-Vega, Mikhail G Dozmorov, Manuel Bernal Quirós, Ying-Yu Wu, Belén Martínez-García, Sergey V Kozyrev, Johan Frostegård, Lennart Truedsson, Enrique de Ramón, María F González-Escribano and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. The Immunogenetics of Systemic Sclerosis.Advances in experimental medicine and biology · 2022
    Article
  4. Immunogenetics of Lupus Erythematosus.Advances in experimental medicine and biology · 2022
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Solving the genetic puzzle of systemic lupus erythematosus.Pediatric nephrology (Berlin, Germany) · 2015
    Review
  14. Article
  15. Article
  16. Review
  17. Clinical perspectives on lupus genetics: advances and opportunities.Rheumatic diseases clinics of North America · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 8 countries.

Angélica M Delgado-VegaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden.
Mikhail G Dozmorov
Manuel Bernal Quirós
Ying-Yu Wu
Belén Martínez-García
Sergey V Kozyrev
Johan Frostegård
Lennart Truedsson
Enrique de Ramón
María F González-Escribano
Norberto Ortego-Centeno
Bernardo A Pons-Estel
Sandra D'Alfonso
Gian Domenico Sebastiani
Torsten Witte
Bernard R Lauwerys
Emoke Endreffy
László Kovács
Carlos Vasconcelos
Berta Martins da Silva
Jonathan D Wren
Javier Martin
Casimiro Castillejo-López
Marta E Alarcón-Riquelme
Oklahoma Medical Research Foundation · USPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESUniversidade do Porto · PTUniversity of Szeged · HUUppsala University · SECliniques Universitaires Saint-Luc · BEConsejo Superior de Investigaciones Científicas · ESHospital Doctor José Molina Orosa · ESHospital Universitario Virgen de las Nieves · ESHospital Universitario Virgen del Rocío · ESIRCCS San Camillo Hospital · ITKarolinska Institutet · SELund University · SEMedizinische Hochschule Hannover · DEUniversidad de Granada · ESUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2004 to 2011
$21.0M
NCRR NIH HHS P20 RR020143NCRR NIH HHS RR020143
6 · The paper itself

Abstract

objectivesTo perform fine mapping of the autoimmunity susceptibility gene BLK and identify functional variants involved in systemic lupus erythematosus (SLE).

methodsGenotyping of 1163 European SLE patients and 1482 controls and imputation were performed covering the BLK gene with 158 single-nucleotide polymorphisms. Logistic regression analysis was done using PLINK and conditional analyses using GENABEL's test score. Transfections of BLK constructs on HEK293 cells containing the novel mutation or the wild type form were analysed for their effect on protein half-life using a protein stability assay, cycloheximide and western blot. CHiP-qPCR for detection of nuclear factor κ B (NFkB) binding.

resultsFine mapping of BLK identified two independent genetic effects with functional consequences: one represented by two tightly linked associated haplotype blocks significantly enriched for NFκB-binding sites and numerous putative regulatory variants whose risk alleles correlated with low BLK mRNA levels. Binding of NFkBp50 and p65 to an associated 1.2 Kb haplotype segment was confirmed. A second independent genetic effect was represented by an Ala71Thr, low-frequency missense substitution with an OR=2.31 (95% CI 1.38 to 3.86). The 71Thr decreased BLK protein half-life.

conclusionsThese results show that rare and common regulatory variants in BLK are involved in disease susceptibility and both, albeit independently, lead to reduced levels of BLK protein.

Indexed as

Genetic Predisposition to DiseaseMutationPolymorphism, Single NucleotideBiomarkersChromosome MappingGene Expression Regulation, EnzymologicGenetic MarkersGenotypeHalf-LifeHEK293 CellsHumansLupus Erythematosus, SystemicNF-kappa BProtein BindingProtein Stabilitysrc-Family KinasesBiomarkersGenetic MarkersNF-kappa Bprotein-tyrosine kinase p55(blk)src-Family Kinases

Identifiers

PMID22696686
PMCPMC3375585
OpenAlexW2132159757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.